drugset / Trial / NCT05522556

Pre-approval Single-patient Expanded Access for Ritlecitinib (PF-06651600)

NCT05522556 ↗

Expanded access Available Pfizer

Summary

Provide pre-approval single patient Expanded Access (compassionate use) of Ritlecitinib for patients.

Timeline

Start
—
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Ritlecitinib Small molecule — —

Indications